accelerated process for granting treatment approval 結果共1筆

Legislators and veterinarian groups in Taiwan are calling for an expedited process to grant treatment approval for Feline Infectious Peritonitis (FIP), a highly fatal disease for cats. FIP is particularly prevalent in cats with weakened immune systems, such as older or younger cats, and has an almost 100% mortality rate. Diagnosing and preventing the disease is challenging, and currently, there are no legal medications for FIP in Taiwan. Legislator Kao Chia-yu, in collaboration with veterinarian groups, is working to provide hope for cats suffering from FIP. Research has shown that GS-441524 tablets have curative effects, but the application process for animal medication has been halted due to the COVID-19 outbreak. During a press conference, the president of the Taiwan Academy of Veterinary Internal Medicine, Chung Sheng-hua, highlighted that Remdesivir, a COVID-19 medication, and Molnupiravir from MSD have also demonstrated effectiveness against FIP. Chung urged relevant authorities to expedite the legalization of these drugs to obtain the necessary animal medication permits.